News
EXCLUSIVE: Neuralink dragged into humane testing lawsuit – Timeline of Events
Neuralink has been dragged into a lawsuit by the Physicians Committee for Responsible Medicine against the University of California at Davis. The lawsuit, which is amended from its initial filing date of May 2021, seeks to have UC Davis release images and video of inhumanely-treated test subjects, including monkeys, who died after participating in some trials of Neuralink-sponsored research for the development of neural interface implant devices. We have put together an exclusive timeline of events based on interviews and an examination of over 700 pages of documents that UC Davis was required to turn over to the PCRM.
The Physicians Committee for Responsible Medicine (PCRM) is a nonprofit organization with more than 17,000 doctor members. It filed a formal complaint with the United States Department of Agriculture today, claiming UC Davis and Neuralink staff violated the federal Animal Welfare Act related to experiments performed on 23 monkeys. Neuralink paid more than $1.4 million to UC Davis to carry out the experiments.
The PCRM said in a press release that Neuralink and the University “failed to provide dying monkeys with adequate veterinary care, used an unapproved substance known as “Bioglue” that killed monkeys by destroying portions of their brains, and failed to provide for the psychological well-being of monkeys assigned to the experiment.”
In an exclusive interview with Teslarati earlier today, Jeremy Beckham, MPA, MPH, PCRM’s Research Advocacy Coordinator, said that the lawsuit really intends to open up “basic facts about what Neuralink testing did to the animals.” Beckham said monkeys had their brains mutilated in the experiments. Veterinary records, which were shared with Teslarati by the PCRM, show that UC Davis and Neuralink staff performed invasive and deadly experiments on monkeys to assess the effectiveness of the Neuralink device. The letter sent from the PCRM to the USDA earlier today gives several graphic descriptions of how the test animals were treated.
RELATED:
Neuralink details humane animal treatment during Link v0.9 testing
One animal, known as “Animal 6,” was a 6-year-old macaque monkey who was killed on January 16, 2019. The letter states that, on October 10, 2018, implanted electrodes “were placed using an investigational robot,” then, “attached to skull using titanium implant screws.” The location of the screws began to become infected, according to the letter. By January 14th, “Animal 6” had started to pick at the infected area. Staff euthanized the monkey two days later.
Timeline of Events
PCRM has been working to clarify the situation since September 2020, but a more descriptive timeline of events would clarify how Neuralink, UC Davis, and the PCRM have all combined into this issue.
- May 2017 – The University of California at Davis and Neuralink sign and agree to Non-Disclosure Agreements regarding testing.
- September 2017 – UC Davis and Neuralink officially begin their collaboration to carry out primate experiments at UC Davis facilities. The goal is to develop a brain-machine interface.
- July 2018 – “Animal 4,” an 11-year-old macaque monkey is killed in the Neuralink/UC Davis experiments, according to the complaint. The monkey was “on anti-depressants and had chronic diarrhea and poor appetite.” Additionally, the monkey was observed as “lethargic” and “depressed,” and hunched and passed bloody diarrhea. The monkey eventually died in a deadly procedure on July 20th.
- Also in July 2018 – “Animal 12,” approximately 7-years-old, undergoes a craniotomy and electrode insertion procedure. Records show the animal had “severe clinical adverse effects following the implantation, had poor stool quality, was not eating, and had an eye infection.” Records abruptly ended on July 30th.
- September 2018 – “Animal 21,” a 7-year-old female macaque undergoes an “electrode insertion survivability” procedure using “investigational robotics.” The animal was observed with adverse side effects the following day, including vomiting, gasping, retching, and had little interaction with their environment and observers. The animal was euthanized and had signs of “Bioglue,” an unapproved adhesive, covering the brain.
- December 2018 – “Animal 15,” a 7-year-old female macaque undergoes a craniotomy and recording device implantation. Following the surgery, the area became infected and bloody. The animal was euthanized on March 21, 2019. The performed necropsy shows “remnant electrode threads.”
- January 2019 – “Animal 6,” a 6-year-old macaque monkey is killed as a part of the “experimental design.” Electrodes were secured by screws drilled into the monkey’s skull, and lab staff were forced to “frequently clean” the eroding skin near the monkey’s implant site.
- March 2019 – “Animal 11” is killed at approximately 11-years-old during a terminal procedure. The monkey had an implant placed on the head or brain on December 3rd, 2018, and began experiencing symptoms like a weakened appetite and missing fingers and toes, possibly caused by self-mutilation.
- January 2020 – “Animal 5,” another macaque monkey is killed “inadvertently” by an anticonvulsant. He showed signs of significant weight loss and alopecia.
- July 2020 – Neuralink’s Elon Musk announces that the company will hold an event on August 28th, 2020, to display the progress of the V0.9 device. “Will show neurons firing in real-time on August 28th. The matrix in the matrix,” Musk said in a Tweet.
- Also in July 2020 – Neuralink receives a ‘breakthrough device’ designation from the FDA in July, and the company is working with the agency to make the technology as safe as possible.
- August 2020 – Neuralink unveils the v0.9 device, displaying healthy and functioning pigs. Musk delivers a presentation on the new device, showing the simplified product Neuralink has developed. “It’s like a FitBit in your skull with tiny wires,” Musk half-joked. “I could have it right now and you wouldn’t even know. Maybe I do!” The device is said to be installed without general anesthesia. There will be no bleeding, and no noticeable damage after the device is implanted.
- September 2020 – The PCRM files a California Public Records request, wishing for information regarding UC Davis trials of the Neuralink device. The request is eventually denied in accordance with California State Code 6255(a), which says that the Agency “shall justify withholding any record by demonstrating that the record in question is exempt under express provisions of this chapter or that on the facts of the particular case the public interest served by not disclosing the record clearly outweighs the public interest served by disclosure of the record.”
- October 2020 – “Animal 10,” an 8-year-old macaque monkey, is shipped to Neuralink’s facility in Fremont. The monkey has significant hair loss, had lesions from “unspecified traumas,” and was exhibiting self-mutilating behavior.
- November 2020 – Neuralink severs ties with UC Davis on November 11. Neuralink then moves seven of the remaining monkeys to its facility in Fremont, California. Beckham said that records show 15 of the 23 monkeys used in the research died or were euthanized at UC Davis. The final monkey’s situation is unclear, but it is possible the animal was reassigned to a different project at UC Davis, Beckham said.
- April 2021 – Neuralink releases a YouTube video of “Pager the Monkey” allegedly playing video games with a wireless neural interface. The video features a nine-year-old Macaque named Pager playing “MindPong” while utilizing a Neuralink device.
- May 2021 – PCRM sues the University of California Davis under the California Public Records Act (CPRA) for not releasing records in September 2020. Before the suit reaches a judicial decision, Counsel for the University of California agrees to release 700 pages of information.
- October 2021 – University of California’s General Counsel turns over files including animal testing records and veterinarian reports to PCRM. More than 700 pages of records are turned over.
- February 2022 – PCRM files a separate complaint with the U.S. Department of Agriculture that alleges the information the organization has already received reveals evidence of violations of Federal Animal Welfare laws.
Moving Forward
Beckham maintains that the main point of the newest filing is to have UC Davis turn over photographs and videos that reveal the inhumane treatment of the animals due to the experiments. There are monkeys convulsing, vomiting, and dying in these labs,” Beckham said. “People want to step in line for the first human trials, and they should see this before they commit to that,” he told Teslarati. Neuralink was set for human trials this year, Musk said last year.
Beckham said that these complaints can take a while to work through the legal system. “In my years of being involved with humane testing litigation, I know that these things can take some time. Maybe up to a year,” he said. “It also depends how much they want to fight back.”
Neuralink did not immediately respond to our requests for comment.
Beckham’s full letter to the USDA is available below.
2022-02-10 PCRM USDA Complaint Re UC Davis and Neuralink (No Exhibits) by Joey Klender on Scribd
I’d love to hear from you! If you have any comments, concerns, or questions, please email me at joey@teslarati.com. You can also reach me on Twitter @KlenderJoey, or if you have news tips, you can email us at tips@teslarati.com.
Tesla became the first company to pass the United States government’s new Advanced Driver Assistance Systems (ADAS) testing with the Model Y, completing each of the new tests with a passing performance.
In a landmark announcement on May 7, the National Highway Traffic Safety Administration (NHTSA) declared the 2026 Tesla Model Y the first vehicle to pass its newly ADAS benchmark under the New Car Assessment Program (NCAP).
Model Y vehicles manufactured on or after November 12, 2025, met rigorous pass/fail criteria for four newly added tests—pedestrian automatic emergency braking, lane keeping assistance, blind spot warning, and blind spot intervention—while also satisfying the program’s original four ADAS requirements: forward collision warning, crash imminent braking, dynamic brake support, and lane departure warning.
The NHTSA has just officially announced that the 2026 @Tesla Model Y is the first vehicle model to pass the agency’s new advanced driver assistance system tests.
2026 Tesla Model Y vehicles, manufactured on or after Nov. 12, 2025, successfully met the new criteria for four… pic.twitter.com/as8x1OsSL5
— Sawyer Merritt (@SawyerMerritt) May 7, 2026
NHTSA administration Jonathan Morrison hailed the achievement as a milestone:
“Today’s announcement marks a significant step forward in our efforts to provide consumers with the most comprehensive safety ratings ever. By successfully passing these new tests, the 2026 Tesla Model Y demonstrates the lifesaving potential of driver assistance technologies and sets a high bar for the industry. We hope to see many more manufacturers develop vehicles that can meet these requirements.”
The updates to NCAP, finalized in late 2024 and effective for 2026 models, reflect growing recognition that ADAS features are no longer optional luxuries but essential tools for preventing crashes.
Pedestrian automatic emergency braking, for instance, targets one of the fastest-rising causes of roadway fatalities, while blind spot intervention and lane keeping assistance address common sources of side-swipes and run-off-road incidents. By incorporating objective, performance-based evaluations rather than mere presence of the technology, NHTSA aims to give buyers clearer data on real-world effectiveness.
This milestone arrives at a pivotal moment when vehicle autonomy is transitioning from science fiction to everyday reality.
Tesla’s Full Self-Driving (FSD) software and the impending rollout of robotaxis underscore a broader industry shift toward higher levels of automation. Yet regulators and consumers remain cautious: safety data must keep pace with technological ambition.
The Model Y’s perfect score on these ADAS benchmarks validates that current driver-assist systems—when engineered rigorously—can dramatically reduce human error, which still accounts for the vast majority of crashes.
For Tesla, the result reinforces its long-standing claim of building the safest vehicles on the road. More importantly, it signals to the entire auto sector that meeting elevated federal standards is achievable and expected.
As autonomy edges closer to Level 3 and beyond, where drivers may disengage more fully, such independent verification becomes critical. It builds public trust, informs purchasing decisions, and accelerates the development of systems that could one day eliminate tens of thousands of annual traffic deaths.
In an era when software-defined vehicles promise transformative mobility, the 2026 Model Y’s NHTSA triumph is more than a manufacturer accolade—it is a regulatory green light that autonomy’s future must be built on proven, testable safety foundations. The bar has been raised. The industry, and the roads we share, will be safer for it.
Tesla is going to fix the nearly 219,000 vehicles that it recalled due to an issue with the rearview camera with a simple software update, giving owners no need to travel to a service center to resolve the problem.
Tesla is formally recalling 218,868 U.S. vehicles after regulators discovered a software glitch that can delay the rearview camera image by up to 11 seconds when drivers shift into reverse.
The affected models include certain 2024-2025 Model 3 and Model Y, as well as 2023-2025 Model S and Model X vehicles running software version 2026.8.6 and equipped with Hardware 3 computers. The National Highway Traffic Safety Administration (NHTSA) determined the lag violates Federal Motor Vehicle Safety Standard 111 on rear visibility and could increase crash risk.
Yet this is no ordinary recall. Owners do not need to schedule a service-center visit, hand over keys, or wait for parts.
Tesla fans call for recall terminology update, but the NHTSA isn’t convinced it’s needed
Tesla identified the issue on April 10, halted further deployment of the faulty firmware the same day, and began pushing a corrective over-the-air (OTA) software update on April 11.
By the time the NHTSA posted the recall notice on May 6, more than 99.92 percent of the affected fleet had already received the fix. Tesla reports no crashes, injuries, or fatalities linked to the glitch.
The episode underscores a deeper problem with regulatory language. For decades, “recall” meant hauling a vehicle to a dealership for hardware repairs or replacements. That definition no longer fits software-defined cars. When a fix arrives wirelessly in minutes — identical to an iPhone update — the term evokes unnecessary alarm and misleads the public about the actual risk and remedy.
Elon Musk has repeatedly called for exactly this change. After earlier NHTSA actions, he stated plainly: “The terminology is outdated & inaccurate. This is a tiny over-the-air software update.” On another occasion, he added that labeling OTA fixes as recalls is “anachronistic and just flat wrong.”
The terminology is outdated & inaccurate. This is a tiny over-the-air software update. To the best of our knowledge, there have been no injuries.
— Elon Musk (@elonmusk) September 22, 2022
Musk’s point is simple: regulators must evolve their vocabulary to match the technology. Traditional recalls involve physical intervention and downtime; OTA updates do not. Retaining the old label distorts consumer perception, inflates perceived defect rates, and slows the industry’s shift to faster, safer software iteration.
Tesla’s rapid, remote remedy demonstrates the safety advantage of over-the-air capability. Problems that once required weeks of dealer appointments are now resolved in hours, often before most owners notice. As more automakers adopt software-first designs, the entire regulatory framework needs to catch up.
Updating “recall” terminology would align language with reality, reduce public confusion, and recognize that modern vehicles are no longer static hardware — they are continuously improving computers on wheels.
For the 219,000 Tesla owners involved, the process is already complete. The camera works, the car is safe, and no one left their driveway. That is the new standard — and the vocabulary should reflect it.
News
Tesla is seeing record sales rebounds in key markets globally
Tesla reported robust sales momentum in April 2026, extending a multi-month recovery in its two largest markets amid intensifying global EV competition.
Tesla is seeing record sales rebounds in key markets across the world, and as skeptics and bears of the company that builds electric powertrains rejoice on the weak registration figures that have been reported in the past, the Musk-fronted company is keen on making a comeback.
Tesla reported robust sales momentum in April 2026, extending a multi-month recovery in its two largest markets amid intensifying global EV competition.
While the company does not release official monthly global delivery figures—reserving those for quarterly reports—data from local registration and wholesale sources show significant year-over-year gains in China and several European countries, building on a turnaround from 2025’s declines.
In China, Tesla’s Shanghai Gigafactory shipped 79,478 Model 3 and Model Y vehicles in April, a 36% increase from the same month last year. The figure marks the sixth consecutive month of year-on-year growth for China-made EVs, which include both domestic sales and exports to Europe and other regions.
Although down slightly from March’s 85,670 units, the April performance underscores Tesla’s resilience against domestic rivals like BYD. Wholesale volumes from the plant have helped Tesla regain ground after softer retail figures earlier in the year, with analysts noting improved demand fueled by competitive pricing and new configurations
Europe also delivered encouraging results. Registrations—a close proxy for sales—surged in multiple countries. France posted a 112 percent jump, Sweden 111%, Denmark 102%, and Ireland 100%. The Netherlands rose 23%, while Belgium and Romania recorded gains of 47% and 53%, respectively.
These double- and triple-digit increases reflect a broader EV market recovery across the continent, where battery-electric vehicle market share climbed to 20.5% in Q1 2026 from 13.2% a year earlier. Chinese brands continue to challenge Tesla’s position in some markets, but the U.S. automaker’s rebound has been widespread in Northern and Western Europe.
Germany, Europe’s largest auto market, contributed to the positive momentum. Although full April registration data had not yet been released as of early May, March’s figures were record-setting: 9,252 Tesla vehicles registered, a staggering 315% increase year-over-year and the company’s strongest March performance in years.
Germany reported 3,149 Tesla sales and 1.3% market share in April. BEV penetration is 25.8% and Tesla has 4.9% of this segment. 🇩🇪
• +256% vs. April last year and +142% compared to January the first month of the previous quarter
• Best April ever
• Highest first month of the… pic.twitter.com/n4MIJv4w6t— Roland Pircher (@piloly) May 7, 2026
That month alone accounted for 72% of Tesla’s Q1 total in Germany (12,829 units, up 160%). Industry observers expect April to follow suit, supported by new EV subsidies and rising fuel prices.
The April figures come after Tesla’s Q1 2026 global deliveries of 358,023 vehicles, which showed modest growth but trailed some analyst expectations. The European and Chinese rebounds suggest accelerating demand heading into Q2, driven by refreshed lineups, competitive pricing, and expanding charging infrastructure.
However, Tesla faces ongoing pressure from lower-cost Chinese competitors and softening demand in select markets like Norway and Portugal, where April registrations fell sharply.
Overall, April’s data paints an optimistic picture for Tesla. The company’s ability to post consistent growth in China while reclaiming share in Europe signals renewed strength after 2025’s challenges.
Investors and analysts will watch closely for May and June numbers as Tesla prepares its Q2 report, which could confirm whether this rebound translates into sustained record-setting momentum. With approximately 450 words, this snapshot highlights how targeted execution is paying dividends in Tesla’s most critical regions
Tesla crushes NHTSA’s brand-new ADAS safety tests – first vehicle to ever pass
Tesla to fix 219k vehicles in recall with simple software update
